Welcome to LookChem.com Sign In|Join Free

CAS

  • or

33927-05-8

Post Buying Request

33927-05-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

33927-05-8 Usage

Uses

Methyl 3,5-Dinitro-4-hydroxybenzoate can be used to reduce a susceptibility to tumor formation.

Check Digit Verification of cas no

The CAS Registry Mumber 33927-05-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,3,9,2 and 7 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 33927-05:
(7*3)+(6*3)+(5*9)+(4*2)+(3*7)+(2*0)+(1*5)=118
118 % 10 = 8
So 33927-05-8 is a valid CAS Registry Number.
InChI:InChI=1/C8H6N2O7/c1-17-8(12)4-2-5(9(13)14)7(11)6(3-4)10(15)16/h2-3,11H,1H3

33927-05-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 4-hydroxy-3,5-dinitrobenzoate

1.2 Other means of identification

Product number -
Other names 4-hydroxy-3,5-dinitro-benzoic acid methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:33927-05-8 SDS

33927-05-8Relevant articles and documents

Amino-benzoic acids and derivatives, and methods of use

-

, (2008/06/13)

The present invention relates to compounds, compositions and methods for inhibiting nonenzymatic cross-linking (protein aging). Accordingly, a composition is disclosed which comprises an agent capable of inhibiting the formation of advanced glycosylation endproducts of target proteins by reacting with a carbonyl moiety of the early glycosylation product of such target proteins formed by their initial glycosylation. The method comprises contacting the target protein with the composition. Both industrial and therapeutic applications for the invention are envisioned, as food spoilage and animal protein aging can be treated.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 33927-05-8